These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9730598)
21. Pattern of FHIT gene expression in normal and leukaemic cells. Yang HW; Piao HY; Taki T; Chen T; Hashizume K; Ohnishi H; Bessho F; Yanagisawa M; Matsuo Y; Hayashi Y Int J Cancer; 1999 Jun; 81(6):897-901. PubMed ID: 10362136 [TBL] [Abstract][Full Text] [Related]
22. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia. Venkatraj VS; Gaidano G; Auerbach AD Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673 [TBL] [Abstract][Full Text] [Related]
23. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis. Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760 [TBL] [Abstract][Full Text] [Related]
24. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736 [TBL] [Abstract][Full Text] [Related]
25. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528 [TBL] [Abstract][Full Text] [Related]
26. Multiple molecular alterations of FHIT in betel-associated oral carcinoma. Chang KW; Kao SY; Tzeng RJ; Liu CJ; Cheng AJ; Yang SC; Wong YK; Lin SC J Pathol; 2002 Mar; 196(3):300-6. PubMed ID: 11857493 [TBL] [Abstract][Full Text] [Related]
27. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Makishima H; Jankowska AM; Tiu RV; Szpurka H; Sugimoto Y; Hu Z; Saunthararajah Y; Guinta K; Keddache MA; Putnam P; Sekeres MA; Moliterno AR; List AF; McDevitt MA; Maciejewski JP Leukemia; 2010 Oct; 24(10):1799-804. PubMed ID: 20724984 [No Abstract] [Full Text] [Related]
28. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines. Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck. Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317 [TBL] [Abstract][Full Text] [Related]
31. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Bugert P; Wilhelm M; Kovacs G Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948 [TBL] [Abstract][Full Text] [Related]
32. FHIT alterations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Tsujiuchi T; Sasaki Y; Murata N; Tsutsumi M; Konishi Y; Nakae D Carcinogenesis; 2001 Dec; 22(12):2017-22. PubMed ID: 11751434 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders. Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372 [TBL] [Abstract][Full Text] [Related]